with limitations in drug total dose , a variety of dose schedules have proven to be tolerable , with a moderate incidence of nausea and vomiting and mild peripheral neuropathy , and a low incidence of more severe peripheral neuropathy or central neuropathy .
C0031117
peripheral neuropathy
C0442874
neuropathy